Vasculitis Affecting Large Arteries

A large vessel essentially refers to the aorta and its largest branches that are directed to the head and neck and the extremities. The hallmark of pathology associated with large vessel vasculitides is that chronic inflammatory lesions are primarily found inside of the walls of vessels and not on the outside.

This is a key distinction that can be used in order to separate large vessel pathology from small vessel pathologies, which present with inflammation on the outside of the vessel wall in addition to being found within. The two main large artery vasculitides that will be discussed below are giant cell arteritis (GCA) and Takayasu arteritis (TA).

Giant Cell Arteritis

Also known as temporal arteritis or Horton’s arteritis, giant cell arteritis is a fairly common systemic vasculitide with a higher prevalence in women and peak incidence almost exclusively after the fifth decade of life. GCA typically has a gradual onset, but an abrupt one is not unheard of. Moreover, it is often associated with polymyalgia rheumatic (an inflammatory disorder causing muscle pain). Most of GCA’s clinical manifestations occur prior to therapy with steroids; however, they may develop during the early phase of treatment or while gradually reducing the dosage of steroid therapy. In addition, a constitutional syndrome consisting of loss or lack of appetite, abnormal physical weakness or lack of energy and weight loss may also commonly occur.

Additional symptoms associated with GCA are carotidynia (carotid artery pain) and the thickening of erythematous, nodular, and tender superficial temporal arteries that may have decreased or absent pulses. Other arteries such as the postauricular, facial and occipital may also be enlarged, with fairly frequent claudication (pain induced by movement due to vessel obstruction) of the jaw. Due to the intense vessel occlusion associated with GCA and the resulting complication of blindness in up to 20% of patients, the condition is considered a medical emergency. Ocular manifestations also indicate increased risk for central nervous system complications such as ischemic stroke. Steroid therapy with calcium and vitamin D supplements is the cornerstone of treatment for GCA. Moreover, in terms of prognosis, there is no associated increase in mortality of patients who are treated with timely diagnosis and appropriate management.

Takayasu Arteritis

TA, like GCA, is a chronic idiopathic as well as a granulomatous vasculitide that principally manifests as a panaortitis. TA leads to segmental stenosis of the vessel, occlusion and dilatation and/or the formation of an aneurysm. The progression of the disorder happens in a three phases, namely (i) systemic phase characterized by the constitutional syndrome similar to the constitution syndrome of GCA, (ii) vasculitic phase where the effects of phase one are compounded with vascular tenderness or pain, and (iii) burnt-out phase that manifests as a fibrotic, pulseless condition due to stenosis of the arteries. In addition to the constitutional syndrome symptoms, patients eventually present with hypertension, bruit sounds heard on auscultation and claudication of the upper and lower extremities.

In stark contrast to GCA, which has a peak incidence in individuals older than 50 years, TA is more prevalent in young adults in the 20s and 30s and has a predilection for females. As is the case with GCA, no predisposing factors have been clearly identified for TA; however, an autoimmune-mediated basis has been suggested by some studies. The mainstay of treatment for TA is corticosteroid therapy, but patients failing to respond may be treated with agents such as methotrexate or interventional surgical procedures that involve balloon dilation and / or stenting.

Further Reading

Last Updated: Feb 26, 2019

Dr. Damien Jonas Wilson

Written by

Dr. Damien Jonas Wilson

Dr. Damien Jonas Wilson is a medical doctor from St. Martin in the Caribbean. He was awarded his Medical Degree (MD) from the University of Zagreb Teaching Hospital. His training in general medicine and surgery compliments his degree in biomolecular engineering (BASc.Eng.) from Utrecht, the Netherlands. During this degree, he completed a dissertation in the field of oncology at the Harvard Medical School/ Massachusetts General Hospital. Dr. Wilson currently works in the UK as a medical practitioner.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Wilson, Damien Jonas. (2019, February 26). Vasculitis Affecting Large Arteries. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/health/Vasculitis-Affecting-Large-Arteries.aspx.

  • MLA

    Wilson, Damien Jonas. "Vasculitis Affecting Large Arteries". News-Medical. 31 October 2024. <https://www.news-medical.net/health/Vasculitis-Affecting-Large-Arteries.aspx>.

  • Chicago

    Wilson, Damien Jonas. "Vasculitis Affecting Large Arteries". News-Medical. https://www.news-medical.net/health/Vasculitis-Affecting-Large-Arteries.aspx. (accessed October 31, 2024).

  • Harvard

    Wilson, Damien Jonas. 2019. Vasculitis Affecting Large Arteries. News-Medical, viewed 31 October 2024, https://www.news-medical.net/health/Vasculitis-Affecting-Large-Arteries.aspx.

Comments

  1. G Corrent G Corrent United States says:

    Good article, but a few points. The calcium and Vit. D aren't treatments for GCA, but help prevent osteoporosis from required long term corticosteroid treatment. Temporal HA is a more common complaint than TA tenderness, and scalp tenderness is another symptom. Labs= ESR, C-reactive protein,

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sinusitis tied to elevated rheumatic disease risk